| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.08 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.09 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.09 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.095 | 0.09 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.087 | 0.09 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.09 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.22 | 0.09 |